Liquidia (LQDA) Shares Outstanding (Diluted Average) (2020 - 2026)

Liquidia (LQDA) recorded quarterly Shares Outstanding (Diluted Average) of $101.1 million in Q1 2026, up 17.49% quarter-over-quarter from $86.1 million in Q4 2025, and up 18.71% on a YoY basis from $85.2 million in Q1 2025.

Liquidia (LQDA) Shares Outstanding (Diluted Average) (2020 - 2026) Analysis & Trends

Liquidia's Shares Outstanding (Diluted Average) history runs 7 years deep, the most recent figure standing at $101.1 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Diluted Average) rose 18.71% year-over-year to $101.1 million; the TTM figure through Mar 2026 stood at $101.1 million (up 18.71% YoY), while the FY2025 annual figure was $86.1 million, up 9.34% from the prior year.
  • Shares Outstanding (Diluted Average) was $101.1 million for Q1 2026 at Liquidia, up from $86.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $101.1 million in Q1 2026 to a low of $52.5 million in Q1 2022.
  • Historically, Shares Outstanding (Diluted Average) has averaged $73.2 million across 5 years, with a median of $75.4 million in 2024.
  • Biggest YoY gain for Shares Outstanding (Diluted Average) was 23.24% in 2023; the steepest drop was 4.2% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $61.0 million in 2022, then rose by 6.62% to $65.0 million in 2023, then grew by 21.1% to $78.7 million in 2024, then increased by 9.34% to $86.1 million in 2025, then rose by 17.49% to $101.1 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $101.1 million (Q1 2026), $86.1 million (Q4 2025), and $85.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 1.18 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 422.40 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 47.20 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 103.40 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 506.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn -
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 228.36 Mn
10 Liquidia 5.74 Bn 5.52 Bn 121.79 Mn 101.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 101.11 Mn
Dec 31, 2025 86.06 Mn
Sep 30, 2025 85.70 Mn
Jun 30, 2025 85.38 Mn
Mar 31, 2025 85.17 Mn
Dec 31, 2024 78.71 Mn
Sep 30, 2024 76.72 Mn
Jun 30, 2024 75.91 Mn
Mar 31, 2024 75.39 Mn
Dec 31, 2023 64.99 Mn
Sep 30, 2023 64.77 Mn
Jun 30, 2023 64.79 Mn
Mar 31, 2023 64.66 Mn
Dec 31, 2022 60.96 Mn
Sep 30, 2022 59.75 Mn
Jun 30, 2022 62.18 Mn
Mar 31, 2022 52.47 Mn
Dec 31, 2021 49.68 Mn
Sep 30, 2021 48.82 Mn
Jun 30, 2021 50.85 Mn